Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVATE Prophylaxis Comparison in Hemophilia A
NCT00243386Phase 4Completed
- Sponsor
- Takeda
- Start
- Jan 2006
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 4 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Takeda. Started Jan 2006; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00243386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243386.